458
A.-P. Xing et al. / Tetrahedron 69 (2013) 455e459
mixture was then stirred at rt for 1 h. THF was distilled off in vacuo,
and then toluene (20 mL) was added. The solid was removed by
filtration through a pad of silica gel, and the solvent was removed
under reduced pressure. The residue was purified by flash chro-
d 42.07, 74.46, 120.67, 121.43, 123.91, 124.26, 125.14, 125.86, 127.19,
128.00, 129.01, 129.52, 130.19, 130.66, 133.53, 145.85, 168.45; HRMS
þ
(ESI) calcd for C51
H34NO
8
P
2
[MþH] : 850.1760, found: 850.1754.
0 0
4.2.5. 1-N-Benzylpyrrolidine-3,4-bis[(R)-1,1 -binaphthyl-2,2 -diyl-
matography (toluene, R
f
¼0.36) and furnished ligand 6a as a white
ꢁ
20
D
0 0
3,3 -di(trimethylsilyl)]phosphite-L-tartaric acid (6e). (R)-3,3 -Trime-
foamy solid (457 mg, 66% yield), mp 173e174 C; ½
a
ꢃ
ꢀ96.4 (c 0.11,
31
1
0
0
CH
2
Cl
2
); P NMR (161 MHz, CDCl
3
)
d
140.17; H NMR (400 MHz,
thylsilyl-1,1 -binaphtyl-2,2 -diol (1.00 g, 2.31 mmol) was azeo-
tropically dried by dissolving it in anhydrous toluene (10 mL)
followed by the evaporation of the solvent (two times) in vacuo.
The dry starting material was then dissolved in toluene (25 mL).
CDCl
3
)
d
1.45 (d, J¼8.0 Hz, 4H), 1.66 (d, J¼16.0 Hz, 12H), 2.13e2.20
(
(
(
m, 4H), 2.55e2.75 (m,12H), 4.53 (s, 2H), 4.85 (d, J¼4.0 Hz, 2H), 6.83
d, J¼8.0 Hz,1H), 6.97e7.01 (m, 5H), 7.08 (d, J¼4.0 Hz, 2H), 7.15e7.18
m, 4H), 7.25 (s,1H); 13C NMR (100 MHz, CDCl
)
d
21.38, 21.57, 26.72,
PCl
(242 mL, 381 mg, 2.77 mmol) and triethylamine (1.3 mL, 0.93 g,
3
3
ꢁ
2
8.09, 41.93, 74.52, 117.78, 124.27, 127.19, 128.06, 128.33, 133.26,
9.2 mmol) were dissolved in toluene (50 mL) at ꢀ5 C and were
ꢁ
1
C
34.13, 136.62, 137.45, 144.77, 169.01; HRMS (ESI) calcd for
added dropwise to the SiMe
3
-binaphthol solution at 0 C. After
þ
ꢁ
51
H
49NNaO
8
P
2
[MþNa] : 888.2831, found: 888.2826.
stirring overnight, the resulting suspension was stirred at 50 C for
1
3
h. After removal of the excessive PCl and toluene, the residue was
0
0
0
4
.2.2. 1-N-Benzylpyrrolidine-3,4-bis[(S)-1,1 -H
8
-binaphthyl-2,2 -diyl]
dissolved in 20 mL of toluene, and then was transferred to another
0
phosphite-
L
-tartaric acid (6b). (S)-1,1 -H
8
-Binaphthyl-2,2 -diyl-
Schlenk flask, and toluene was removed in vacuo to obtain a yellow,
31
chlorophosphite 5b was synthesized by the same procedure as that
of 5a, and was used directly without further purification. Treatment
of compound 4 (132.7 mg, 0.6 mmol), 5b (632 mg, 1.76 mmol), and
DMAP (14.6 mg, 0.12 mmol) as described for the synthesis of ligand
air-sensitive powder 5e ( P NMR d 175.48 ppm). This compound
was not characterized further, but used immediately in next re-
actions. Treatment of compound 4 (177 mg, 0.8 mmol), 5e (832 mg,
1.68 mmol), and DMAP (19.5 mg, 0.16 mmol) as described for the
synthesis of ligand 6a afforded ligand 6e, which was purified by
6
a afforded ligand 6b, which was purified by flash chromatography
(
toluene, R
f
¼0.40) to produce a white solid (301 mg, 58% yield), mp
flash chromatography (toluene, R
f
¼0.24) to produce a white solid
ꢁ
20
D
31
ꢁ
20
D
31
1
50e151 C; ½
a
ꢃ
þ270.1 (c 0.11, CH
2
Cl
1.18 (s, 3H),1.45e1.48 (m, 3H),
.67e1.71 (m, 9H), 2.16e2.21 (m, 4H), 2.27 (s, 2H), 2.54e2.61 (m,
H), 2.66e2.74 (m, 7H), 4.63 (s, 2H), 4.86 (d, J¼4.0 Hz, 2H), 6.80 (d,
J¼8.0 Hz, 2H), 6.89e6.94 (m, 4H), 6.99 (d, J¼8.0 Hz, 2H), 7.05e7.10
m, 1H), 7.15e7.19 (m, 2H), 7.26e7.29 (m, 2H), 7.34e7.36 (m, 2H);
2
); P NMR (161 MHz, CDCl
3
)
(383 mg, 42% yield), mp 79e80 C; ½
a
ꢃ
ꢀ259.3 (c 0.68, CH
2
Cl
2
);
P
1
1
d
142.69; H NMR (400 MHz, CDCl
3
)
d
NMR (161 MHz, CDCl
3
)
d
137.31; H NMR (400 MHz, CDCl
3
)
d
0.33 (s,
1
3
18H), 0.41 (s, 18H), 4.18 (d, J¼4.0 Hz, 1H), 4.50 (s, 2H), 4.87e4.91 (m,
1H), 6.96 (d, J¼8.0 Hz, 1H), 7.10e7.11 (m, 4H), 7.17e7.18 (m, 4H),
7.22e7.23 (m, 4H), 7.31e7.34 (m, 4H), 7.80e7.85 (m, 4H), 7.99e8.02
13
(
(m, 4H); C NMR (100 MHz, CDCl
3
) d 0, 42.67, 73.37, 122.62, 125.25,
1
3
3
C NMR (100 MHz, CDCl ) d 21.44, 21.61, 26.74, 28.13, 41.93, 74.64,
126.59, 128.17, 128.66, 128.93, 130.59, 131.11, 134.62, 136.72, 137.30,
1
18.30, 124.27, 127.38, 128.01, 128.23, 133.12, 134.08, 136.41, 137.56,
151.19, 169.91, 172.14; HRMS (ESI) calcd for C63
H
65NO
8
P
2
Si
4
[M-
þ
þ
144.77, 168.87; HRMS (ESI) calcd for C51
H
49NNaO
8
P
2
[MþNa] :
CH
5
Si] : 1092.3101, found: 1092.4630.
8
88.2831, found: 888.2826.
0
0
4
.2.6. 1-N-Benzylpyrrolidine-3,4-bis[(S)-1,1 -binaphthyl-2,2 -diyl-
0
0
0
0
4
.2.3. 1-N-Benzylpyrrolidine-3,4-bis[(R)-1,1 -binaphthyl-2,2 -diyl]
3,3 -di(trimethylsilyl)]phosphite-
L
-tartaric
acid
(6f). (S)-1,1 -
0
0
0
0
phosphite-
L
-tartaric acid (6c). (R)-1,1 -Binaphthyl-2,2 -diyl-chlor-
Binaphthyl-2,2 -diyl-3,3 -di(trimethylsilyl)chlorophosphite 5f was
synthesized by the same procedure as that of 5e, and was used
directly without further purification. Treatment of compound 4
(177 mg, 0.8 mmol), 5f (832 mg, 1.68 mmol), and DMAP (19.5 mg,
0.16 mmol) as described for the synthesis of ligand 6a afforded li-
gand 6f, which was purified by flash chromatography (toluene,
ophosphite 5c was synthesized by the same procedure as that of 5a,
and was used directly without further purification. Treatment of
compound 4 (132.7 mg, 0.6 mmol), 5c (632 mg, 1.76 mmol), and
DMAP (14.6 mg, 0.12 mmol) as described for the synthesis of ligand
6
a afforded ligand 6c, which was purified by flash chromatography
(
1
CDCl
4
4
(
(
toluene, R
f
¼0.63) to produce a white solid (204 mg, 40% yield), mp
R
f
¼0.21) to produce a white solid (301 mg, 58% yield), mp
ꢁ
20
D
31
ꢁ
20
D
31
57e158 C; ½
a
ꢃ
ꢀ297.2 (c 0.11, CH
2
Cl
2
); P NMR (161 MHz,
90e91 C; ½
a
ꢃ
þ320.3 (c 0.39, CH
2
Cl
2
); P NMR (161 MHz, CDCl
3
)
1
1
3
)
d
142.80; H NMR (400 MHz, CDCl
3
)
d
4.50 (dd, J¼20.0,
d
136.39; H NMR (400 MHz, CDCl
3
)
d
0.34 (s, 18H), 0.41 (s, 18H),
.0 Hz, 2H), 4.93 (d, J¼16.0 Hz, 2H), 7.09e7.11 (m, 2H), 7.17e7.18 (m,
4.18 (d, J¼4.0 Hz, 1H), 4.51 (s, 2H), 4.87e4.91 (m, 1H), 6.96 (d,
H), 7.21e7.24 (m, 4H), 7.27e7.31 (m, 4H), 7.33e7.41 (m, 5H), 7.49
J¼8.4 Hz, 1H), 7.10e7.12 (m, 4H), 7.17e7.18 (m, 4H), 7.22e7.24 (m,
13
d, J¼12.4 Hz, 2H), 7.56 (d, J¼8.0 Hz, 2H), 7.72 (d, J¼8.0 Hz, 2H), 7.86
4H), 7.37e7.41 (m, 4H), 7.80e7.91 (m, 4H), 7.99e8.06 (m, 4H);
C
13
d, J¼8.0 Hz, 2H), 7.92 (d, J¼8.0 Hz, 2H); C NMR (100 MHz, CDCl
3
)
3
NMR (100 MHz, CDCl ) d 0, 42.66, 73.35, 122.61, 125.25, 126.59,
128.18, 128.66, 128.94, 130.58, 131.09, 134.61, 136.72, 137.30, 151.19,
169.92, 172.15; HRMS (ESI) calcd for C63
1087.3340, found: 1087.0484.
d
43.04, 75.65, 121.60, 122.43, 124.18, 125.08, 126.43, 126.94, 128.33,
þ
1
(
28.78, 130.10, 130.64, 131.18, 132.72, 134.34, 146.79, 169.53; HRMS
ESI) calcd for C51
H65NO P
8 2
Si
4
[MꢀH
3
PO] :
þ
H
33NNaO
8
P
2
[MþNa] : 872.1579, found: 872.1574.
0
0
4
.2.4. 1-N-Benzylpyrrolidine-3,4-bis[(S)-1,1 -binaphthyl-2,2 -diyl]
4.3. Representative procedure for the 1,4-addition of Et
2-cyclohexenone 7a
2
Zn to
0
0
phosphite-
L
-tartaric acid (6d). (S)-1,1 -Binaphthyl-2,2 -diyl-chlor-
ophosphite 5d was synthesized by the same procedure as that of
a, and was used directly without further purification. Treatment of
5
2 6 6
A solution of (CuOTf) $C H (0.0025 mmol,1.3 mg) and ligand 6c
compound 4 (177 mg, 0.8 mmol), 5d (617 mg, 1.76 mmol), and
DMAP (19.5 mg, 0.16 mmol) as described for the synthesis of ligand
(0.005 mmol, 4.3 mg) in ether (4 mL) was stirred for 1 h at rt under
nitrogen. After the solution was cooled to 0 C, 2-cyclohexenone 7a
ꢁ
6
a afforded ligand 6d, which was purified by flash chromatography
(0.25 mmol, 0.025 mL) was added and the solution was stirred for
ꢁ
(
toluene, R
f
¼0.56) to produce a white solid (326 mg, 48% yield), mp
10 min at 0 C. Then Et
2
Zn (1.2 mmol, 1.2 mL of 1.0 M solution in
ꢁ
20
D
31
1
CDCl
38e139 C; ½
a
ꢃ
þ191.7 (c 0.16, CH
2
Cl
2
); P NMR (161 MHz,
hexane) was added dropwise using a syringe within 2 min. After
4 h, the reaction was quenched by H O (2 mL) and 2 M HCl (2 mL),
and extracted with ethyl acetate (5 mLꢂ3). The combined organic
layer was washed with saturated NaHCO solution, brine, and then
dried over anhydrous Na SO , filtered, and concentrated in vacuo to
obtain the crude product. The conversion and the yield were
1
3
)
d
146.65; H NMR (400 MHz, CDCl
3
)
d
4.54 (dd, J¼20.0,
2
4
5
.4 Hz, 2H), 4.94 (d, J¼4.0 Hz, 2H), 7.06e7.09 (m, 3H), 7.14e7.18 (m,
H), 7.24e7.26 (m, 3H), 7.28e7.29 (m, 2H), 7.31e7.35 (m, 5H), 7.39
3
(
(
d, J¼4.0 Hz, 3H), 7.47 (d, J¼8.0 Hz, 2H), 7.52 (d, J¼8.0 Hz, 2H), 7.82
2
4
13
d, J¼8.8 Hz, 2H), 7.88 (d, J¼8.0 Hz, 2H); C NMR (100 MHz, CDCl
3
)